Symposium: The Gut Microbiota and Disease - Session I

Symposium: The Gut Microbiota and Disease - Session I

Tuesday, April 27, 2021 • 8:30 AM - 11:30 AM (EST)

 

Xiao-Ming Yin, MD, PhDChair
Xiao-Ming Yin, MD, PhD
Tulane University

Wenke Feng, PhDCo-Chair
Wenke Feng, PhD
University of Louisville

Maria Pilar Alcaide, PhDCo-Chair
Maria Pilar Alcaide, PhD
Tufts University 

Jose Otero, MD, PhDCo-Chair
José Otero, MD, PhD
The Ohio State University

Session Description: Humans carry a vast number of bacteria and other microbiota species from birth, and you may be more bacteria than you are you.  An increasing importance of microbiota in human health and diseases has been recognized.  Whatever your research subjects are, chances are that they may be influenced by the microbiota.  This symposium will discuss the impact of gut microbiota on diseases ranging from neurodegeneration to diabetes, from the liver to the heart, and from the immune cells to the bone.

 

  Chair - Welcome and Introductions  
8:30 AM - 9:00 AM Gut Microbiota, Bile Acids Receptor, and Metabolism
John YL Chiang, PhD • Northeast Ohio Medical University
John YL Chiang, PhD
9:05 AM - 9:35 AM Hepatic Autophagy, Microbiota, and Liver Injury
Xiao-Ming Yin, MD, PhD • Tulane University
Xiao-Ming Yin, MD, PhD
9:40 AM - 10:10 AM Gut Microbiota, Fatty Liver Disease, and Hepatocellular Carcinoma
Bernd Schnabl, MD • University of California, San Diego
Bernd Schnabl, MD
10:15 AM - 10:45 AM Intestinal Barrier Function and Metabolic Liver Disease
Wenke Feng, PhD • University of Louisville
Wenke Feng, PhD
10:50 AM - 11:20 AM Fecal Transplantation and Immune Regulation in Liver Disease
Shirish Barve, PhD • University of Louisville
Shirish Barve, PhD
11:25 AM - 11:30 AM Closing Remarks